Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-23-021720
Filing Date
2023-02-14
Accepted
2023-02-14 16:32:01
Documents
1
Group Members
DALIA BLEYERNEXTECH V GP S.A R.L.THOMAS LIPS

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm236484d1_sc13ga.htm SC 13G/A 96509
  Complete submission text file 0001104659-23-021720.txt   98082
Mailing Address 7, RUE LOU HEMMER LUXEMBOURG-FINDEL N4 L-1748
Business Address 7, RUE LOU HEMMER LUXEMBOURG-FINDEL N4 L-1748 352-246-160-6000
Nextech V Oncology S.C.S., SICAV-SIF (Filed by) CIK: 0001712922 (see all company filings)

EIN.: 000000000 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 11975 EL CAMINO REAL, STE 101 SAN DIEGO CA 92130
Business Address 11975 EL CAMINO REAL, STE 101 SAN DIEGO CA 92130 8582994699
Kinnate Biopharma Inc. (Subject) CIK: 0001797768 (see all company filings)

EIN.: 824566526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91893 | Film No.: 23630258
SIC: 2834 Pharmaceutical Preparations